Agenus (AGEN) Change in Acquisitions & Divestments (2010 - 2026)
Agenus (AGEN) posted quarterly Change in Acquisitions & Divestments of $7000.0 for Q1 2026, down 88.71% year-over-year from $62000.0 in Q1 2025, and up 111.29% quarter-over-quarter from -$62000.0 in Q4 2025.
Analysis
Agenus (AGEN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Agenus' Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 88.71% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at -$55000.0 (down 114.59% YoY), while the FY2024 annual figure was $579000.0, up 1602.94% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $7000.0, up from -$62000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $15.0 million in Q3 2023, with the low at -$30.0 million in Q4 2023.
- The 5-year median for Change in Acquisitions & Divestments is $264000.0 (2024), against an average of $1.7 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 200.0% in 2023, while the deepest fall reached 699.32% in 2023.
- Agenus' Change in Acquisitions & Divestments stood at $5.0 million in 2022, then sank by 699.32% to -$30.0 million in 2023, then surged by 100.17% to $52000.0 in 2024, then plunged by 219.23% to -$62000.0 in 2025, then surged by 111.29% to $7000.0 in 2026.
- Business Quant data shows AGEN's Change in Acquisitions & Divestments at $7000.0 in Q1 2026, -$62000.0 in Q4 2025, and $62000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Agenus | 344.35 Mn | 344.35 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 779,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 264,000.00 |
| Sep 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2017 | 5.00 Mn |
| Sep 30, 2017 | 10.00 Mn |
| Mar 31, 2017 | 5.00 Mn |
| Dec 31, 2016 | 15.00 Mn |
| Sep 30, 2016 | 35.00 Mn |